1.11
1.11 (0.04%)
As of Dec 22, 2020
Kineta, Inc. [PTI]
Source:
Company Overview
Kineta is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Kineta has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer therapy.
Country | United States |
Headquarters | seattle, washington |
Phone Number | (206) 378-0400 |
Industry | manufacturing |
CEO | Shawn Iadonato, Ph.D. |
Website | kinetabio.com |